Meghan Sri Karuturi Selected Research

Fluoxymesterone (Halotestin)

11/2016

Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meghan Sri Karuturi Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 11/2019 - 11/2016
2	Neoplasms (Cancer) 03/2020 - 01/2019
1	Body Weight (Weight, Body) 03/2020
1	Malnutrition (Nutritional Deficiencies) 03/2020
1	Frailty 03/2020
1	Weight Loss (Weight Reduction) 03/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2019
1	Disease Progression 11/2016
1	Hematologic Neoplasms (Hematological Malignancy) 07/2013
1	Death (Near-Death Experience) 07/2013

Drug/Important Bio-Agent (IBA)

2	Hormones (Hormone)IBA 01/2019 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2017
2	Estrogen ReceptorsIBA 01/2019 - 11/2016
2	Androgen Receptors (Androgen Receptor)IBA 09/2017 - 11/2016
1	Cyclin-Dependent Kinase 4IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	palbociclibIBA 01/2019
1	Fluoxymesterone (Halotestin)FDA Link 11/2016

Therapy/Procedure

5	Therapeutics 11/2019 - 07/2013
2	Drug Therapy (Chemotherapy) 11/2019 - 07/2013
1	Home Nursing (Nursing, Home) 03/2020